KYMR
Price
$46.08
Change
+$1.36 (+3.04%)
Updated
Sep 13 closing price
52 days until earnings call
QURE
Price
$5.70
Change
+$0.04 (+0.71%)
Updated
Sep 16, 09:37 AM (EDT)
43 days until earnings call
Ad is loading...

KYMR vs QURE

Header iconKYMR vs QURE Comparison
Open Charts KYMR vs QUREBanner chart's image
Kymera Therapeutics
Price$46.08
Change+$1.36 (+3.04%)
Volume$381.22K
CapitalizationN/A
uniQure
Price$5.70
Change+$0.04 (+0.71%)
Volume$3.23K
CapitalizationN/A
View a ticker or compare two or three
KYMR vs QURE Comparison Chart
Loading...
KYMR
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
QURE
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
KYMR vs. QURE commentary
Sep 16, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KYMR is a Hold and QURE is a StrongSell.

COMPARISON
Comparison
Sep 16, 2024
Stock price -- (KYMR: $46.08 vs. QURE: $5.66)
Brand notoriety: KYMR and QURE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KYMR: 78% vs. QURE: 12%
Market capitalization -- KYMR: $2.98B vs. QURE: $275.63M
KYMR [@Biotechnology] is valued at $2.98B. QURE’s [@Biotechnology] market capitalization is $275.63M. The market cap for tickers in the [@Biotechnology] industry ranges from $606.91B to $0. The average market capitalization across the [@Biotechnology] industry is $3.05B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KYMR’s FA Score shows that 0 FA rating(s) are green whileQURE’s FA Score has 0 green FA rating(s).

  • KYMR’s FA Score: 0 green, 5 red.
  • QURE’s FA Score: 0 green, 5 red.
According to our system of comparison, QURE is a better buy in the long-term than KYMR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KYMR’s TA Score shows that 3 TA indicator(s) are bullish while QURE’s TA Score has 4 bullish TA indicator(s).

  • KYMR’s TA Score: 3 bullish, 5 bearish.
  • QURE’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, QURE is a better buy in the short-term than KYMR.

Price Growth

KYMR (@Biotechnology) experienced а +1.50% price change this week, while QURE (@Biotechnology) price change was +4.43% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.56%. For the same industry, the average monthly price growth was +4.67%, and the average quarterly price growth was -1.44%.

Reported Earning Dates

KYMR is expected to report earnings on Nov 07, 2024.

QURE is expected to report earnings on Oct 29, 2024.

Industries' Descriptions

@Biotechnology (+2.56% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KYMR($2.98B) has a higher market cap than QURE($276M). KYMR YTD gains are higher at: 80.990 vs. QURE (-16.396). KYMR has higher annual earnings (EBITDA): -152.44M vs. QURE (-204.63M). QURE (524M) and KYMR (510M) have equal amount of cash in the bank . KYMR has less debt than QURE: KYMR (88.2M) vs QURE (119M). KYMR has higher revenues than QURE: KYMR (88.6M) vs QURE (27.7M).
KYMRQUREKYMR / QURE
Capitalization2.98B276M1,078%
EBITDA-152.44M-204.63M74%
Gain YTD80.990-16.396-494%
P/E RatioN/AN/A-
Revenue88.6M27.7M320%
Total Cash510M524M97%
Total Debt88.2M119M74%
FUNDAMENTALS RATINGS
QURE: Fundamental Ratings
QURE
OUTLOOK RATING
1..100
52
VALUATION
overvalued / fair valued / undervalued
1..100
46
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
60
P/E GROWTH RATING
1..100
89
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
KYMRQURE
RSI
ODDS (%)
Bearish Trend 4 days ago
82%
Bullish Trend 4 days ago
73%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
86%
Bullish Trend 4 days ago
67%
Momentum
ODDS (%)
Bearish Trend 4 days ago
87%
N/A
MACD
ODDS (%)
Bearish Trend 4 days ago
86%
N/A
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
81%
Bullish Trend 4 days ago
73%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
83%
Bearish Trend 4 days ago
87%
Advances
ODDS (%)
Bullish Trend 7 days ago
85%
Bullish Trend 4 days ago
74%
Declines
ODDS (%)
Bearish Trend 5 days ago
87%
Bearish Trend 8 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
75%
Bullish Trend 4 days ago
70%
Aroon
ODDS (%)
Bullish Trend 4 days ago
85%
Bearish Trend 4 days ago
88%
View a ticker or compare two or three
Ad is loading...
KYMR
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
QURE
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TRHBX24.610.60
+2.50%
Nuveen Small Cap Blend Idx I
GSESX68.160.51
+0.75%
Goldman Sachs US Equity Insights Svc
GMJPX13.580.10
+0.74%
Goldman Sachs Real Estate Securities P
RWBEX66.810.42
+0.63%
American Funds Capital World Gr&Inc R2E
HERCX9.750.03
+0.31%
Hartford Emerging Markets Equity C

KYMR and

Correlation & Price change

A.I.dvisor indicates that over the last year, KYMR has been loosely correlated with RXRX. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if KYMR jumps, then RXRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KYMR
1D Price
Change %
KYMR100%
+3.04%
RXRX - KYMR
51%
Loosely correlated
+1.08%
CRSP - KYMR
50%
Loosely correlated
+6.65%
EDIT - KYMR
49%
Loosely correlated
+5.33%
NTLA - KYMR
49%
Loosely correlated
+6.77%
PRME - KYMR
48%
Loosely correlated
+0.99%
More

QURE and

Correlation & Price change

A.I.dvisor indicates that over the last year, QURE has been loosely correlated with PIRS. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if QURE jumps, then PIRS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To QURE
1D Price
Change %
QURE100%
+2.17%
PIRS - QURE
60%
Loosely correlated
-2.11%
HOOK - QURE
44%
Loosely correlated
-2.16%
SNGX - QURE
44%
Loosely correlated
+5.25%
AXON - QURE
42%
Loosely correlated
-1.27%
KYMR - QURE
41%
Loosely correlated
+3.04%
More